Patient Safety Organizations: Voluntary Relinquishment for the Chicago Breast Cancer Quality Consortium, 53658-53659 [2021-21072]

Download as PDF 53658 Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices Freedom of Information Office at https://www.federalreserve.gov/foia/ Sunshine Act Meeting request.htm. Interested persons may express their views in writing on the TIME AND DATE: Thursday, September 30, standards enumerated in the BHC Act 2021 at 10:00 a.m. (12 U.S.C. 1842(c)). PLACE: Virtual meeting. Note: Because of Comments regarding each of these the Covid-19 pandemic, we will applications must be received at the conduct the open meeting virtually. If Reserve Bank indicated or the offices of you would like to access the meeting, the Board of Governors, Ann E. see the instructions below. Misback, Secretary of the Board, 20th STATUS: This meeting will be open to the Street and Constitution Avenue NW, public. To access the virtual meeting, go Washington DC 20551–0001, not later to the commission’s website than October 28, 2021. www.fec.gov and click on the banner to A. Federal Reserve Bank of be taken to the meeting page. Minneapolis (Chris P. Wangen, Assistant Vice President), 90 Hennepin MATTERS TO BE CONSIDERED: Avenue, Minneapolis, Minnesota Draft Advisory Opinion 2021–09: 55480–0291: Certified Voter 1. Frandsen Financial Corporation, Statement of Reasons in Support of Arden Hills, Minnesota; to acquire Bank Repayment Determination After Administrative Review—Dr. Jill Stein, of Zumbrota, Zumbrota, Minnesota and Pine Island Bank, Pine Island, Jill Stein for President (LRA #1021) Campaign Guide for Congressional Minnesota. Candidates and Committees B. Federal Reserve Bank of Kansas Management and Administrative City (Jeffrey Imgarten, Assistant Vice Matters President) 1 Memorial Drive, Kansas CONTACT PERSON FOR MORE INFORMATION: City, Missouri 64198–0001: 1. First Western Financial, Inc., Judith Ingram, Press Officer ,Telephone: Denver, Colorado; to merge with Teton (202) 694–1220. Financial Services, Inc., Wilson, (Authority: Government in the Sunshine Act, Wyoming, and thereby indirectly 5 U.S.C. 552b) acquire Rocky Mountain Bank, Jackson, Vicktoria J. Allen, Wyoming. FEDERAL ELECTION COMMISSION Acting Deputy Secretary of the Commission. [FR Doc. 2021–21119 Filed 9–24–21; 11:15 am] BILLING CODE 6715–01–P [FR Doc. 2021–21028 Filed 9–27–21; 8:45 am] FEDERAL RESERVE SYSTEM BILLING CODE P Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s VerDate Sep<11>2014 16:35 Sep 27, 2021 Jkt 253001 Board of Governors of the Federal Reserve System, September 23, 2021. Michele Taylor Fennell, Deputy Associate Secretary of the Board. FEDERAL RETIREMENT THRIFT INVESTMENT BOARD Notice of Employee Thrift Advisory Council Meeting October 19, 2021 at 10 a.m. Telephonic. Dial-in (listen only) information: Number: 1–415–527– 5035, Code: 2764 577 0210; or via web: https://tspmeet.webex.com/tspmeet/ onstage/g.php?MTID=e93b203932e7 c4905279e93a87109ab84. FOR FURTHER INFORMATION CONTACT: Kimberly Weaver, Director, Office of External Affairs, (202) 942–1640. SUPPLEMENTARY INFORMATION: DATES: ADDRESSES: Meeting Agenda 1. Approval of the May 26, 2021 Joint Board/ETAC Meeting Minutes 2. Thrift Savings Fund Statistics 3. Legislative Update 4. FY2022 FRTIB Budget 5. Participant Satisfaction Report 6. Converge Update PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 7. New Business Authority: 5 U.S.C. 552b(e)(1). Dated: September 22, 2021. Dharmesh Vashee, General Counsel, Federal Retirement Thrift Investment Board. [FR Doc. 2021–20976 Filed 9–27–21; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Patient Safety Organizations: Voluntary Relinquishment for the Chicago Breast Cancer Quality Consortium Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS). ACTION: Notice of delisting. AGENCY: The Patient Safety and Quality Improvement Final Rule (Patient Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to list as a patient safety organization (PSO) an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety and Quality Improvement Act of 2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. AHRQ accepted a notification of proposed voluntary relinquishment from the Chicago Breast Cancer Quality Consortium, PSO number P0074, of its status as a PSO, and has delisted the PSO accordingly. DATES: The delisting was effective at 12:00 Midnight ET (2400) on September 14, 2021. ADDRESSES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. Both directories can be accessed electronically at the following HHS website: https://www.pso.ahrq.gov/listed. FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B, Rockville, MD 20857; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@ahrq.hhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: E:\FR\FM\28SEN1.SGM 28SEN1 Federal Register / Vol. 86, No. 185 / Tuesday, September 28, 2021 / Notices Background The Patient Safety Act, 42 U.S.C. 299b–21 to 299b–26, and the related Patient Safety Rule, 42 CFR part 3, published in the Federal Register on November 21, 2008 (73 FR 70732– 70814), establish a framework by which individuals and entities that meet the definition of provider in the Patient Safety Rule may voluntarily report information to PSOs listed by AHRQ, on a privileged and confidential basis, for the aggregation and analysis of patient safety work product. The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity are to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs. The Patient Safety Rule authorizes AHRQ to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of PSOs. AHRQ has accepted a notification of proposed voluntary relinquishment from the Chicago Breast Cancer Quality Consortium to voluntarily relinquish its status as a PSO. Accordingly, the Chicago Breast Cancer Quality Consortium, P0074, was delisted effective at 12:00 Midnight ET (2400) on September 14, 2021. Chicago Breast Cancer Quality Consortium has patient safety work product (PSWP) in its possession. The PSO will meet the requirements of section 3.108(c)(2)(i) of the Patient Safety Rule regarding notification to providers that have reported to the PSO and of section 3.108(c)(2)(ii) regarding disposition of PSWP consistent with section 3.108(b)(3). According to section 3.108(b)(3) of the Patient Safety Rule, the PSO has 90 days from the effective date of delisting and revocation to complete the disposition of PSWP that is currently in the PSO’s possession. More information on PSOs can be obtained through AHRQ’s PSO website at https://www.pso.ahrq.gov. VerDate Sep<11>2014 16:35 Sep 27, 2021 Jkt 253001 Dated: September 23, 2021. Marquita Cullom, Associate Director. [FR Doc. 2021–21072 Filed 9–27–21; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Rescission of Humanitarian Exemption for All Afghan Evacuees Subject to CDC’s Global Testing Order Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces rescission of the temporary humanitarian exemption to the agency’s Requirement for Negative Pre-Departure COVID–19 Test Result, which was previously granted for individuals relocating to the United States from Afghanistan (‘‘Afghan Evacuees’’), including U.S. citizens, lawful permanent residents (LPRs), third country nationals, and Afghans at risk, including Afghan Special Immigrant Visa (SIV) applicants. DATES: This temporary humanitarian exemption to the Global Testing Order was rescinded September 20, 2021. FOR FURTHER INFORMATION CONTACT: Tiffany Brown, Deputy Chief of Staff, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–10, Atlanta, GA 30329. Phone: 404–639–7000. Email: cdcregulations@ cdc.gov. SUPPLEMENTARY INFORMATION: On January 12, 2021, CDC issued an Order requiring all air passengers arriving to the U.S. from a foreign country to get tested no more than 3 days before their flight departs and to present the negative result or documentation of having recovered from COVID–19 to the airline or aircraft operator before boarding the flight. A copy of the Order was published in the Federal Register on January 21, 2021 (86 FR 6337) and went into effect January 26, 2021. In August 2021, the U.S. Department of State (DOS) issued a series of Security Alerts for Afghanistan due to increased Taliban activity throughout the country, including the capital of Kabul. In response to a request from DOS on August 15, 2021, CDC and the U.S. Department of Health and Human SUMMARY: PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 53659 Services (HHS) granted a blanket humanitarian exemption to CDC’s Order to expedite the evacuation of U.S. citizens, lawful permanent residents (LPRs), third country nationals, and Afghans at risk, including Afghan Special Immigrant Visa (SIV) applicants, while adhering to other COVID–19 mitigation guidance issued by CDC. The exemption, which is being administered with the assistance of DOS and other cooperating Federal and state agencies, was granted with the following conditions: (1) The CDC Order requiring mask use for passengers and crew on air conveyances bound for the United States should be followed to the extent possible; (2) all efforts should be made to test for COVID–19 at a transit location prior to arrival in the United States, and to provide test documentation to the traveler, which can be presented upon arrival, and if this cannot be done, individuals (travelers) arriving are required to undergo COVID–19 testing immediately upon arrival to the first port of entry in the United States; (3) individuals who test positive are required to isolate prior to continuing on commercial transportation to their final destination; and (4) family members of those testing positive may be required to adhere to self-quarantine recommendations as stipulated by CDC or state and local health authorities at the arrival location. Beginning September 20, 2021, all Afghan Evacuees arriving in the United States will have to meet negative predeparture COVID–19 test requirements or documentation of recovery. This means evacuees will need to be tested no more than three days before departure to the United States and be able to present the negative result or provide documentation of having recovered from COVID–19 within the last 90 days, to the airline or aircraft operator and upon request of United States Government authorities on arrival in the United States. This requirement applies to all Afghan Evacuees arriving in the United States on any flight including U.S. Government-owned or -contracted, commercial, private, and general and business aviation (chartered) flights coming to the United States. CDC is rescinding the humanitarian exemption because: • The Department of State (DOS) has completed the emergency evacuation and concluded the transport of evacuees out of Afghanistan; • With DOS’s conclusion of emergency evacuation from Afghanistan, there is a need to resume appropriate health interventions, including pre-departure COVID–19 E:\FR\FM\28SEN1.SGM 28SEN1

Agencies

[Federal Register Volume 86, Number 185 (Tuesday, September 28, 2021)]
[Notices]
[Pages 53658-53659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21072]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Patient Safety Organizations: Voluntary Relinquishment for the 
Chicago Breast Cancer Quality Consortium

AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department 
of Health and Human Services (HHS).

ACTION: Notice of delisting.

-----------------------------------------------------------------------

SUMMARY: The Patient Safety and Quality Improvement Final Rule (Patient 
Safety Rule) authorizes AHRQ, on behalf of the Secretary of HHS, to 
list as a patient safety organization (PSO) an entity that attests that 
it meets the statutory and regulatory requirements for listing. A PSO 
can be ``delisted'' by the Secretary if it is found to no longer meet 
the requirements of the Patient Safety and Quality Improvement Act of 
2005 (Patient Safety Act) and Patient Safety Rule, when a PSO chooses 
to voluntarily relinquish its status as a PSO for any reason, or when a 
PSO's listing expires. AHRQ accepted a notification of proposed 
voluntary relinquishment from the Chicago Breast Cancer Quality 
Consortium, PSO number P0074, of its status as a PSO, and has delisted 
the PSO accordingly.

DATES: The delisting was effective at 12:00 Midnight ET (2400) on 
September 14, 2021.

ADDRESSES: The directories for both listed and delisted PSOs are 
ongoing and reviewed weekly by AHRQ. Both directories can be accessed 
electronically at the following HHS website: https://www.pso.ahrq.gov/listed.

FOR FURTHER INFORMATION CONTACT: Cathryn Bach, Center for Quality 
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, MS 06N100B, 
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone 
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local): 
(301) 427-1130; Email: [email protected].

SUPPLEMENTARY INFORMATION:

[[Page 53659]]

Background

    The Patient Safety Act, 42 U.S.C. 299b-21 to 299b-26, and the 
related Patient Safety Rule, 42 CFR part 3, published in the Federal 
Register on November 21, 2008 (73 FR 70732-70814), establish a 
framework by which individuals and entities that meet the definition of 
provider in the Patient Safety Rule may voluntarily report information 
to PSOs listed by AHRQ, on a privileged and confidential basis, for the 
aggregation and analysis of patient safety work product.
    The Patient Safety Act authorizes the listing of PSOs, which are 
entities or component organizations whose mission and primary activity 
are to conduct activities to improve patient safety and the quality of 
health care delivery.
    HHS issued the Patient Safety Rule to implement the Patient Safety 
Act. AHRQ administers the provisions of the Patient Safety Act and 
Patient Safety Rule relating to the listing and operation of PSOs. The 
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that 
attests that it meets the statutory and regulatory requirements for 
listing. A PSO can be ``delisted'' if it is found to no longer meet the 
requirements of the Patient Safety Act and Patient Safety Rule, when a 
PSO chooses to voluntarily relinquish its status as a PSO for any 
reason, or when a PSO's listing expires. Section 3.108(d) of the 
Patient Safety Rule requires AHRQ to provide public notice when it 
removes an organization from the list of PSOs.
    AHRQ has accepted a notification of proposed voluntary 
relinquishment from the Chicago Breast Cancer Quality Consortium to 
voluntarily relinquish its status as a PSO. Accordingly, the Chicago 
Breast Cancer Quality Consortium, P0074, was delisted effective at 
12:00 Midnight ET (2400) on September 14, 2021.
    Chicago Breast Cancer Quality Consortium has patient safety work 
product (PSWP) in its possession. The PSO will meet the requirements of 
section 3.108(c)(2)(i) of the Patient Safety Rule regarding 
notification to providers that have reported to the PSO and of section 
3.108(c)(2)(ii) regarding disposition of PSWP consistent with section 
3.108(b)(3). According to section 3.108(b)(3) of the Patient Safety 
Rule, the PSO has 90 days from the effective date of delisting and 
revocation to complete the disposition of PSWP that is currently in the 
PSO's possession.
    More information on PSOs can be obtained through AHRQ's PSO website 
at https://www.pso.ahrq.gov.

    Dated: September 23, 2021.
Marquita Cullom,
Associate Director.
[FR Doc. 2021-21072 Filed 9-27-21; 8:45 am]
BILLING CODE 4160-90-P